Dr Reddy’s And Hikma Win Big On US Vascepa Patents
Hikma Considering At-Risk Launch If Originator Appeals
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
